FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and Immunology, and concerns treating Systemic Lupus Erythematosus. That is ensured by integrated treatment, consisting of two ten-days stages. First stage involves intramuscular introduction of preparations of interferon, anti aggregants and/or detoxification therapy combined autohemotherapy in form of mixture in one syringe of auto blood in amount of 2 ml and human immunoglobulin normal in amount of 1.5 ml for following 5 days. Second stage involves oral introduction of interferon inductors and intravenous infusion therapy with hepatoprotectors. Such courses of treatment is carried out once in three months. Therapeutic courses are repeated to normalize immunological, laboratory values and improving clinical presentation of patient.
EFFECT: method provides the stable remission at decrease of dependence of cytostatic agents and glucocorticosteroids.
3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH DEHYDROEPIANDROSTERONE | 2000 |
|
RU2248207C2 |
| AGENT FOR TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSIS | 1997 |
|
RU2157684C2 |
| USE OF A DERIVATIVE GLUTARIMIDE TO OVERCOME RESISTANCE TO STEROIDS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT SIGNALING OF INTERFERON GAMMA | 2018 |
|
RU2712281C1 |
| METHOD OF ARRESTING HEPATITE "C" CHRONISATION | 2007 |
|
RU2331436C1 |
| METHOD OF TREATING DISSEMINATED LICHEN ACUMINATUS ASSOCIATED WITH CHRONIC GRANULOMATOUS PERIODONTITIS | 2019 |
|
RU2703313C1 |
| METHOD FOR DIAGNOSING THE NEED TO PRESCRIBE GLUCOCORTICOIDS SYSTEMICALLY IN PATIENTS WITH RHEUMATIC DISEASE | 2021 |
|
RU2760260C1 |
| METHOD OF TREATING CHRONIC OSTEOMYELITIS IN ANIMALS | 2008 |
|
RU2377011C1 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
| METHOD FOR COMPLEX THERAPY IN PATIENTS WITH SKIN MELANOMA | 2006 |
|
RU2318452C1 |
| TREATMENT OF PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 2008 |
|
RU2356574C1 |
